| BCBS Massachusetts | Pharmacy-MED_UM_Policy_SP | 2026-01-15 |
| BCBS Massachusetts | Soliris, Ultomiris, Complement 3 Glomerulopathy (C3G), Myasthenia Gravis, Paroxysmal nocturnal hemoglobinuria (PNH), and Neuromyelitis Optica Policy | 2026-01-15 |
| BCBS Massachusetts | Topical Ocular Hydrating Agents | 2026-01-15 |
| BCBS Massachusetts | Veozah Step Policy | 2026-01-15 |
| BCBS Massachusetts | Oncology Drugs | 2026-01-15 |
| Cigna | Gender Dysphoria Treatment - (0266) | 2026-01-15 |
| Medical Mutual | Adakveo ® (crizanlizumab-tmca) | 2026-01-15 |
| Medical Mutual | Benlysta® (belimumab injection for intravenous use)* | 2026-01-15 |
| Medical Mutual | Cabenuva® (cabotegravir extended-release | 2026-01-15 |
| Medical Mutual | Cosentyx ® (secukinumab injection for intravenous | 2026-01-15 |